Australia Markets closed


Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
7.600.00 (0.00%)
As of 01:08PM CEST. Market open.
Full screen
Previous close7.60
Bid7.35 x 0
Ask7.90 x 0
Day's range7.60 - 7.60
52-week range6.15 - 13.80
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Evolus, Inc. (EOLS) Reports Q4 Loss, Tops Revenue Estimates

    Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -14.29% and 0.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Simply Wall St.

    Institutional investors own a significant stake of 39% in Evolus, Inc. (NASDAQ:EOLS)

    To get a sense of who is truly in control of Evolus, Inc. ( NASDAQ:EOLS ), it is important to understand the ownership...

  • Motley Fool

    Why Evolus Shares Jumped This Week

    Shares of Evolus (NASDAQ: EOLS) were up by 27.1% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence. The medical aesthetics company specializes in using neurotoxins as aesthetic therapies. The company said in its announcement that it expected fourth-quarter revenue of $43.6 million, up 26% year over year, and full-year revenue of $148.6 million, up 49% over 2021.